STAAR Surgical to Present at the 20th Annual Oppenheimer Healthcare Conference
in New York
MONROVIA, Calif., Oct. 27 /PRNewswire-FirstCall/ -- STAAR Surgical Company
(Nasdaq: STAA), a leading developer, manufacturer and marketer of minimally
invasive ophthalmic products, today announced today that Deborah Andrews,
Chief Financial Officer, will present at the 20th Annual Oppenheimer
Healthcare Conference at The Waldorf-Astoria Hotel on Wednesday, November 4th
at 3:55 p.m. Eastern Time.
Interested parties can access a live audio web cast of the presentation at
www.staar.com. A replay of the presentation will be available at the same
location.
About STAAR Surgical
STAAR Surgical is a leader in the development, manufacture and marketing of
minimally invasive ophthalmic products employing proprietary technologies.
STAAR's products are used by ophthalmic surgeons and include the Visian® ICL,
a tiny, flexible lens implanted to correct refractive errors, as well as
innovative products designed to improve patient outcomes for cataracts and
glaucoma. Manufactured in Switzerland by STAAR, the ICL is approved by the
FDA for use in treating myopia, has received CE Marking and is sold in more
than 50 countries. Collamer® is the brand name for STAAR's proprietary
collagen copolymer lens material. More information is available at
www.staar.com.
CONTACT: Investors Media
EVC Group EVC Group
Douglas Sherk, 415-896-6820 Chris Gale 646-201-5431
Mike Pollock, 415-896-6820
SOURCE STAAR Surgical Company
Investors, Douglas Sherk or Mike Pollock, +1-415-896-6820, or Media, Chris
Gale, +1-646-201-5431, all of EVC Group, for STAAR Surgical Company
